GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genenta Science SPA (NAS:GNTA) » Definitions » Other Current Receivables

Genenta Science SPA (Genenta Science SPA) Other Current Receivables : $2.19 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Genenta Science SPA Other Current Receivables?

Genenta Science SPA's Other Current Receivables for the quarter that ended in Dec. 2023 was $2.19 Mil.

Genenta Science SPA's quarterly Other Current Receivables increased from Dec. 2022 ($1.66 Mil) to Jun. 2023 ($2.10 Mil) and increased from Jun. 2023 ($2.10 Mil) to Dec. 2023 ($2.19 Mil).

Genenta Science SPA's annual Other Current Receivables increased from Dec. 2021 ($1.61 Mil) to Dec. 2022 ($1.66 Mil) and increased from Dec. 2022 ($1.66 Mil) to Dec. 2023 ($2.19 Mil).


Genenta Science SPA Other Current Receivables Historical Data

The historical data trend for Genenta Science SPA's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genenta Science SPA Other Current Receivables Chart

Genenta Science SPA Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Other Current Receivables
0.48 0.93 1.61 1.66 2.19

Genenta Science SPA Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Current Receivables Get a 7-Day Free Trial Premium Member Only 1.61 1.98 1.66 2.10 2.19

Genenta Science SPA Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.


Genenta Science SPA Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Genenta Science SPA's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Genenta Science SPA (Genenta Science SPA) Business Description

Traded in Other Exchanges
Address
Via Olgettina No. 58, Milan, ITA, 20132
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's lead product includes Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.